|
Search
Collections
Benchmarks
Upload document
Organization
Oracle Life Sciences
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
Time toxicity for patients receiving oral versus parenteral hypomethylating agents for myelodysplastic syndromes/neoplasms (MDS).
Org:
Epstein Health, LLC,
Oracle Life Sciences,
